B7+ T Cells in Myeloma: an Acquired Marker of Prior Chronic Antigen Presentation
Authors:
- 1 February 2004
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 45 (2) , 363-371
Abstract
Murine T cells do not endogenously upregulate CD80 expression but rather acquire CD80 from antigen presenting cells (APC) during CD28 ligation. Murine CD80+ memory T cells undergo apoptosis in the presence of high levels of antigen while naive CD80+ T cells are capable of acting as APC and T cell : T cell ligation induces anergy and unresponsiveness to antigen rechallenge. Reversing T cell unresponsiveness may be a key factor in the development of immunotherapy strategies for patients with myeloma. We have determined that B7+ T cells (CD80+ or CD86 + ) are common in patients with myeloma (n = 45), can be either CD4 or CD8, tend to be associated with stable disease and are polyclonal memory T cells (CD45RO). CD80 mRNA expression was present in CD80+ monocytes but not in CD3+ cells with a similar level of CD80 antigen expression. CD80 and CD86 antigen expression was upregulated on B cells but not T cells during incubation with trimeric human CD40 ligand (huCD40LT) + IL-2. Although there was a gradual loss of expression during in vitro culture, CD80+ T cells could be purified for further study. We conclude that B7 expression is common on T cells of patients with myeloma but that this is acquired rather than endogenously produced. B7+ CD45RO+ T cells constitute a population of memory T cells chronically exposed to antigen and warrant further study.Keywords
This publication has 9 references indexed in Scilit:
- Feline Immunodeficiency Virus Infection Is Characterized by B7+CTLA4+T Cell ApoptosisThe Journal of Infectious Diseases, 2002
- Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10Blood, 2001
- Cross-presentation of tumor antigens by bone marrow–derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progressionBlood, 2001
- Vaccination of multiple myeloma patients with idiotype‐pulsed dendritic cells: immunological and clinical aspectsBritish Journal of Haematology, 2000
- The Expression of LFA-1,ICAM-1,CD80 and CD86 Molecules in Lupus Patiens: Implication for Immunotherapy.Internal Medicine, 1999
- The B7 and CD28 receptor familiesImmunology Today, 1994
- Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.Proceedings of the National Academy of Sciences, 1993
- T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.Proceedings of the National Academy of Sciences, 1990
- Immunization with the Light Chain and the VL Domain of the Isologous Myeloma Protein 315 Inhibits Growth of Mouse Plasmacytoma MOPC315Scandinavian Journal of Immunology, 1980